Holen Sie sich die Stockscreener-App
218.73
1.88%
4.04
Handel nachbörslich:
222.04
3.31
+1.51%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KLAC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$214.69
Offen:
$213.385
24-Stunden-Volumen:
8.65M
Relative Volume:
0.71
Marktkapitalisierung:
$285.72B
Einnahmen:
$13.09B
Nettoeinkommen (Verlust:
$4.67B
KGV:
61.84
EPS:
3.5373
Netto-Cashflow:
$4.01B
1W Leistung:
-0.29%
1M Leistung:
-10.54%
6M Leistung:
+44.59%
1J Leistung:
+143.82%
1-Tages-Spanne:
$212.86
$219.03
1-Wochen-Bereich:
$204.58
$221.00
52-Wochen-Spanne:
$83.22
$307.37
Kla Corp Stock (KLAC) Company Profile
Firmenname
Kla Corp
Sektor
Telefon
(408) 875-3000
Adresse
ONE TECHNOLOGY DRIVE, MILPITAS, CA
Compare KLAC vs ASML, AMAT, LRCX, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KLAC
Kla Corp
|
218.73 | 280.44B | 13.09B | 4.67B | 4.01B | 3.5373 |
ASML
Asml Holding Nv
|
1,803.00 | 692.09B | 41.20B | 12.41B | 11.15B | 32.12 |
AMAT
Applied Materials Inc
|
562.80 | 439.79B | 29.02B | 8.51B | 5.34B | 10.64 |
LRCX
Lam Research Corp
|
319.78 | 399.29B | 21.68B | 6.71B | 6.00B | 5.298 |
TER
Teradyne Inc
|
373.75 | 57.84B | 3.79B | 854.06M | 553.18M | 5.4031 |
Kla Corp Stock (KLAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-14 | Eingeleitet | Bernstein | Outperform |
| 2026-01-13 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-12-16 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-12-15 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-30 | Bestätigt | TD Cowen | Hold |
| 2025-10-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-09-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-08-01 | Bestätigt | TD Cowen | Hold |
| 2025-07-10 | Eingeleitet | Goldman | Neutral |
| 2025-07-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-01 | Bestätigt | TD Cowen | Hold |
| 2025-04-11 | Bestätigt | Oppenheimer | Outperform |
| 2025-03-31 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-28 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-13 | Hochstufung | Needham | Hold → Buy |
| 2024-10-31 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-10-31 | Bestätigt | TD Cowen | Hold |
| 2024-09-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-07-25 | Bestätigt | TD Cowen | Hold |
| 2024-07-15 | Bestätigt | Citigroup | Buy |
| 2024-06-05 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-26 | Bestätigt | TD Cowen | Hold |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Buy |
| 2024-01-29 | Herabstufung | Susquehanna | Positive → Neutral |
| 2024-01-26 | Bestätigt | TD Cowen | Market Perform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-18 | Eingeleitet | New Street | Buy |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Neutral |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-06-14 | Herabstufung | Needham | Buy → Hold |
| 2023-04-06 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-01-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-01-18 | Fortgesetzt | Stifel | Buy |
| 2022-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-03-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-01-12 | Bestätigt | Barclays | Equal Weight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-21 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-15 | Bestätigt | Deutsche Bank | Buy |
| 2021-11-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | Cowen | Market Perform |
| 2021-10-28 | Bestätigt | Credit Suisse | Outperform |
| 2021-10-28 | Bestätigt | Deutsche Bank | Buy |
| 2021-10-28 | Bestätigt | Goldman | Neutral |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Piper Sandler | Neutral |
| 2021-10-28 | Bestätigt | Stifel | Buy |
| 2021-10-28 | Bestätigt | Susquehanna | Positive |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-28 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-17 | Bestätigt | BofA Securities | Buy |
| 2021-09-14 | Hochstufung | Susquehanna | Neutral → Positive |
| 2021-07-30 | Bestätigt | Cowen | Market Perform |
| 2021-07-30 | Bestätigt | Deutsche Bank | Buy |
| 2021-07-30 | Hochstufung | Needham | Hold → Buy |
| 2021-07-30 | Bestätigt | Stifel | Buy |
| 2021-07-30 | Bestätigt | UBS | Neutral |
| 2021-06-09 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-02-04 | Bestätigt | Cowen | Market Perform |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-08-04 | Bestätigt | Cowen | Market Perform |
| 2020-07-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-17 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-05-26 | Eingeleitet | Barclays | Equal Weight |
| 2020-04-08 | Fortgesetzt | Exane BNP Paribas | Outperform |
| 2020-03-27 | Hochstufung | UBS | Sell → Neutral |
| 2020-02-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-02-05 | Bestätigt | Cowen | Outperform |
| 2019-11-21 | Herabstufung | UBS | Neutral → Sell |
| 2019-11-20 | Eingeleitet | Nomura | Buy |
| 2019-10-31 | Bestätigt | Cowen | Outperform |
| 2019-09-18 | Bestätigt | Cowen | Outperform |
| 2019-09-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-08-06 | Bestätigt | Cowen | Outperform |
| 2019-07-22 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-20 | Eingeleitet | Wells Fargo | Market Perform |
| 2019-05-07 | Bestätigt | Cowen | Outperform |
| 2019-04-17 | Eingeleitet | Needham | Hold |
Alle ansehen
Kla Corp Aktie (KLAC) Neueste Nachrichten
AMSL, AMAT, KLAC, LRCX: Chipmaking Equipment Stocks Rise On Intel’s CapEx Bump - TradingView
KLA (KLAC) Rides The AI Chip Rally, Is The Upside Already Priced In? - simplywall.st
Earnings Preview: KLA Corp to Report Financial Results Post-market on July 28 - Moomoo
KLA (KLAC) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
KLA Corp. stock outperforms competitors despite losses on the day - MarketWatch
What Makes KLA Corporation (KLAC) an Attractive Bet? - Yahoo Finance
KLA Corp (KLAC) Shares Surge 4.8% -- What GF Score of 80 Tells I - GuruFocus
Is AI Euphoria Outrunning KLA’s (KLAC) Earnings Reality And Reframing Its Investment Story? - simplywall.st
Intel, KLA Corporation, Lam Research, Marvell Technology, and Micron Shares Skyrocket, What You Need To Know - Yahoo Finance
KLA Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
KLA Corp Stock (KLAC) Moved Up by 4.31% on Jul 21: Facts Behind the Movement - TradingKey
KLA (KLAC) to Release Quarterly Earnings on Tuesday - MarketBeat
KLA stock trades steady as chip equipment orders support outlook - Ad-hoc-news.de
KLA Corp. (KLAC) Adjusted Price Target and Analyst Rating Update - GuruFocus
UBS Cuts Price Targets On Arm Holdings (NASDAQ: ARM), Qualcomm (NASDAQ: QCOM), And KLA Corp. (NASDAQ: KLAC) - foreignpolicyjournal.com
UBS Adjusts Price Target on KLA to $240 From $255, Maintains Neutral Rating - Moomoo
KLA Corp. stock underperforms Monday when compared to competitors - MarketWatch
KLA Price Target Cut to $240.00/Share From $255.00 by UBS - Moomoo
KLA Corporation stock holds firm as revenue reaches $3.84 billion - Ad-hoc-news.de
KLA Corp (NASDAQ:KLAC) Is a Quality Stock With Durable Competitive Advantages and Strong Cash Generation - ChartMill
KLA Corporation tokenized stock (xStock) Price History and Historical Data - CoinMarketCap
KLA Corp (KLAC) Shares Fall 3.0% -- What GF Score of 84 Tells In - GuruFocus
Kla Corporation (KLAC) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
Kla Corporation (KLAC) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
KLA Corporation (KLAC) Price Forecast: Bearish Breakdown Signals More Downside - FXEmpire
Lobbying Update: $290,000 of KLA CORPORATION lobbying was just disclosed - Quiver Quantitative
KLA stock holds firm as chip equipment maker balances strong margins with softer near term demand - Ad Hoc News
Kla Corporation (KLAC) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Kla Corporation (KLAC) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Kla Corporation (KLAC) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
$100 Invested In KLA 10 Years Ago Would Be Worth This Much Today - Benzinga
KLAC Maintains Outperform Rating by Oppenheimer -- Price Target Raised to $260 - GuruFocus
KLA’s Earnings Could Show AI Chip Gear Still Tight - Finimize
KLA Fiscal Q4 Seen Highlighting AI Demand Strength Amid Valuation Concerns, Oppenheimer Says - Moomoo
Oppenheimer Adjusts Price Target on KLA to $260 From $200, Maintains Outperform Rating - Moomoo
Why Has KLA Corporation (KLAC) Outperformed the Market - Kavout | AI
Oppenheimer raises KLA stock price target to $260 on AI demand - Investing.com
The Technical Signals Behind (KLAC) That Institutions Follow - Stock Traders Daily
KLA (KLAC) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Singapore
Applied Materials Vs. KLA Corporation: This AI Infrastructure Play Is A Better Buy - Yahoo Finance
KLAC Maintained by UBS -- Price Target Raised to $255 - GuruFocus
Stock Traders Purchase Large Volume of KLA Call Options (NASDAQ:KLAC) - MarketBeat
KLA Corp Stock (KLAC) Moved Down by 4.93% on Jul 15: Facts Behind the Movement - TradingKey
UBS Maintains KLA Corp(KLAC.US) With Hold Rating, Raises Target Price to $255 - Moomoo
KLA (KLAC) Stock Looks Pricey On Earnings After A 7x Run - simplywall.st
KLA Corporation rated Strong Buy with $313 targ... - Pluang
I Am Buying KLA Corporation Ahead Of Earnings (NASDAQ:KLAC) - Seeking Alpha
Applied Materials, KLA Corporation, and Teradyne Shares Skyrocket, What You Need To Know - Yahoo Finance
Is KLA Corp (KLAC) Overvalued After 3.6% Rally? GF Value Says Ov - GuruFocus
KLA Corp. stock outperforms competitors on strong trading day - MarketWatch
KLA Climbs as Chip-Equipment Sentiment Improves Ahead of Earnings - Quiver Quantitative
Finanzdaten der Kla Corp-Aktie (KLAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kla Corp-Aktie (KLAC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kirloskar Virendra A | SVP & Chief Accounting Officer |
Jul 02 '26 |
Sale |
265.69 |
196 |
52,075 |
19,575 |
| Wilkinson Mary Beth | EVP, CLO and Secretary |
Jul 01 '26 |
Sale |
285.30 |
14,392 |
4,106,038 |
53,367 |
0.15%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):